These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Clinical characteristics and prognosis of various immunocytological subvariants of acute lymphoblastic leukemia in children]. Klubovskaia NI; Tsveĭbakh AS; Petrova EM; Pustovalova AG; Bessonova AG Pediatriia; 1989; (2):30-4. PubMed ID: 2726363 [TBL] [Abstract][Full Text] [Related]
23. Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentation. van't Veer MB; van Putten WL; Verdonck LF; Ossenkoppele GJ; Löwenberg B; Kluin-Nelemans JC; Wijermans PW; Schouten HC; Sizoo W; Dekker AW Ann Hematol; 1993 Jun; 66(6):277-82. PubMed ID: 7686403 [TBL] [Abstract][Full Text] [Related]
24. Shifts in expression of immunological cell markers in relapsed acute leukemia. Tomová A; Babusíková O Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283 [TBL] [Abstract][Full Text] [Related]
25. [Human acute leukemia. II. Acute lymphoblastic leukemia. Complex classification of acute leukemia]. Lemez P Sb Lek; 1990 Jan; 92(1):23-32. PubMed ID: 2330503 [TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression. Klobusická M; Babusíková O Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667 [TBL] [Abstract][Full Text] [Related]
27. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Li S; Juco J; Mann KP; Holden JT Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942 [TBL] [Abstract][Full Text] [Related]
28. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079 [TBL] [Abstract][Full Text] [Related]
29. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428 [TBL] [Abstract][Full Text] [Related]
30. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens]. Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339 [TBL] [Abstract][Full Text] [Related]
36. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta. Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945 [TBL] [Abstract][Full Text] [Related]
37. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype. Babusíková O; Tomová A Neoplasma; 2002; 49(5):312-8. PubMed ID: 12458329 [TBL] [Abstract][Full Text] [Related]
38. Immunological Subtypes of Acute Lymphoblastic Leukemia- Beyond Morphology: Experience from Kidwai State Cancer Institute, Bengaluru, India. Rajkumar NN; Vijay RH J Assoc Physicians India; 2017 Jul; 65(7):14-17. PubMed ID: 28792162 [TBL] [Abstract][Full Text] [Related]
39. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Janossy G; Coustan-Smith E; Campana D Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463 [TBL] [Abstract][Full Text] [Related]
40. Immunological subtypes of acute lymphoblastic leukemia in north India. Bhargava M; Kumar R; Karak A; Kochupillai V; Arya LS; Mohanakumar T Leuk Res; 1988; 12(8):673-8. PubMed ID: 3184984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]